The assay combines transcriptome profiling with clinical risk factors to detect early prostate cancer and provide a risk assessment for aggressive disease.
The new TeloSizer service from Genomic Vision uses molecular combing to offer quantitative telomere length assessments.
The method, called HPV-Seq, detected ctDNA with high sensitivity and specificity, and could help hone precision treatments of HPV-related cancers.
Understanding DNA methylation's role in cell state transitions could enable new therapies that target oncogenic state changes, new research suggests.
The assay from a Stanford and UCSF team allows clinicians to scan for multiple cancers of the central nervous system and to reanalyze past samples.
Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response.
In data presented at the ESMO Congress, a signature of eight proteins and two clinical parameters appeared to differentiate responders and non-responders.
The company is using real-word data and machine-learning algorithms to help customers identify and address gaps in precision medicine access and research.
Scientists are adapting a computational approach often used to find cancer treatments to finding new medicines for COVID-19 patients.